Intermediate for Sitagliptin. Sitagliptin ( trade name Januvia) is an orally bioavailable dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type-2 diabetes. Sitagliptin has been approved by the U.S Food and Drug Administration on Oct 17, 2006.


Product Name:                  5-[1-Hydroxy-2-(2,4,5-trifluorophenyl)ethylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione

Synonyms:                         N/A

CAS Number:                     764667-64-3

Molecular Weight:            316.2331

Molecular Formula:          C14H11F3O5

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               OC(=C1C(=O)OC(OC1=O)(C)C)Cc1cc(F)c(cc1F)F

  • $69.00
  • Ex Tax: $69.00

Available Options